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In the past, there has been considerable 
pessimism about our ability to identify the preg­
nant patient at risk. However, with the develop­
ment of sophisticated diagnostic techniques 
these patients can be identified and with appro­
priate treatment their outcome can be im­
proved. This paper presents the overall benefit 
of categorizing obstetrical patients, the method 
that has been developed at the Medical College 
of Virginia (MCV), and certain categories of 
high-risk obstetrical patients who continue to 
present problems and have unacceptably high 
complication rates. 
A variety of systems has recently ap­
peared in the literature designed to categorize 
the high-risk obstetrical patient' To be success­
ful such a system must be accurate and simple 
enough to understand. Some of the initial sys­
tems of categorization were simply too com­
plicated They involved the tabulation of mul­
tiple factors drawn from virtually every aspect of 
the patient's lifestyle, physical examination, and 
laboratory assessment Consequently, they 
were too cumbersome to be practical The goal 
of any identification system should be to sepa­
rate patients into groups which can then be 
managed according to the common require­
ments of each group. 
The classification system used at MCV is 
based on the premise that a given pregnancy 
may represent a progressive risk to the fetus or 
the mother and that this risk can be attenuated 
by appropriate care. Not included in the system 
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are patients at risk for congenital anomalies. 
This group of patients undergoes comprehen­
sive early antenatal evaluation. The results of 
this evaluation are then made available to the 
parents. who in turn determine what action is to 
be taken. On the other hand, there is a larger 
group of patients whose pregnancies are at pro­
gressive risk in utero. Identification, classifica­
tion and appropriate intervention can improve 
perinatal outcome in this larger group. 
The MCV identification system is divided 
into four categories. It was recognized at the 
outset that obstetrical patients could not simply 
be separated into normal patients and high-risk 
patients If this were done, 90% of the patients 
would be in the high-risk category and only 
1 0% in the normal category Instead, it seemed 
more logical to group patients according to the 
severity of their problems. 
Class IV Critical care pregnancies 
Eclampsia 
Severe preeclampsia 
Chronic hypertension with superim­
posed preeclampsia 
Chronic renal disease uncompensated 
(creatinine 1 .2 mg/% or greater) 
Organic heart disease uncompensated 
(early signs of failure) 
Hemoglobinopathies in crisis 
Pyelonephritis, acute 
Premature rupture of the membranes 
Premature dilatation of the cervix in the 
second half of pregnancy 
Diabetes (ketonuria) 
Placental accidents (abruptio placenta 
and placenta previa in the second 
half of pregnancy) 
Class Ill High-risk pregnancy 
Mild preeclampsia 
Diabetes without evidence of ketonuria 
Chronic hypertension 
Chronic renal disease compensated 
(creatinine less than 1 .2 mg/%) 
Organic heart disease compensated 
(no signs of failure) 
Hemoglobinopathy, disease stable 
(hemoglobin less than 1 0 gm%) 
Rhesus negative, sensitized 
Previous intrauterine fetal demise in 
second half of pregnancy 
Proven intrauterine growth retardation 
Maternal weight loss 
Gestational age documented greater 
than 4 2 weeks 
Multiple pregnancy 
Maternal weight greater than 300 
pounds 
Deficiency anemias (hemoglobin less 
than 1 0 gm/%) 
Class II At-risk pregnancy 
Maternal weight between 250 and 300 
pounds 
Hemoglobinopathy, trait (hemoglobin 
10 gm/% or greater) 
Deficiency anemias (hemoglobin 1 0 
gm/% or greater) 
History of urinary tract infections 
Bacteriuria 
Rhesus negative, unsensitized 
Suspected intrauterine growth retarda-
tion 
Inadequate maternal weight gain 
Previous cesarean section 
Previous premature baby 
Previous baby 1 0 pounds or greater 
Class I Normal pregnant patients 
Critical care pregnancies (Class IV) are 
those pregnancies in which there is an imminent 
possibility of decompensation. As is apparent 
from the diagnoses, there is a risk of death to 
the fetus or the mother. These patients should 
generally be cared for in the hospital. 
High-risk pregnancies (Class Ill) include 
those that are not quite as critical as the Class 
IV type but whose diagnoses carry an unaccep­
tably high perinatal loss. This is the category at 
which all the "new" antepartum testing tech-
niques and methods of management have been 
directed. Specialized high-risk obstetrical clinics 
have been developed in referral centers to eval­
uate and closely follow patients in this category. 
The most substantial improvement in perinatal 
outcome can be realized in the Class Ill cate­
gory. 
At-risk pregnancies (Class II) need to be 
identified but do not require specialized surveil­
lance. From the nature of the diagnoses it is ap­
parent that all these patients have the capacity 
to decompensate and therefore require close 
supervision. 
Low-risk pregnancies (Class I) include pa­
tients with normal pregnancies Frequently, the 
least number of patients are found in this cate­
gory. These are patients with normal histories, 
normal physical examinations and normal labo­
ratory values. Their pregnancies follow the pro­
jected course for fundal growth, maternal 
weight gain, blood pressure, and all other pa­
rameters of normal pregnancy. 
It is important to note that the assignment 
of a classification does not mean that the pa­
tient is necessarily going to remain in that classi­
fication throughout the pregnancy. Patients may 
shift from one class to another as their status 
improves or worsens. For example, if a patient 
has an iron deficiency anemia with hemoglobin 
of 11 gm/% she is placed in the Class II cate­
gory. She is counseled about nutrition and ap­
propriate diet, and iron supplements are pre­
scribed. If, however, her hemoglobin drops to 9 
gm/% as her pregnancy progresses, she is 
then placed in the Class Ill category. This may 
mean that she is transferred from a routine ob­
stetrical clinic to a high risk clinic with special­
ized surveillance. 
There are several diagnoses contained in 
the classification system that are of special in­
terest. One such diagnosis is maternal weight 
loss (Class Ill). 
In the past, not enough attention has been 
paid to adequate weight gain in pregnancy. A 
great deal of emphasis has been placed on ex­
cessive weight gain yet poor weight gain or 
worse, weight loss, has not been so readily rec­
ognized. It is important to realize that the corre­
lation between low-birth-weight infants and lack 
of maternal weight gain is greater than with any 
other single factor. When charts are examined 
retrospectively for factors such as parity, so­
cioeconomic status, maternal weight gain, lox-
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emia, renal disease. cigarette smoking, and 
number of children, the greatest influence on 
fetal weight gain is maternal weight gain. 
Poor fetal weight gain is not necessarily 
due to the fact that the mother's nutritional 
status is inadequate. Maternal weight gain is 
predicted both on her nutritional status and on 
the size of her fetus. If there is a problem pre­
venting the growth of the fetus, such as rubella, 
the mother will not gain weight. This mother can 
be fed an adequate diet. but the baby will not 
grow because of its limited potential. Decreased 
maternal weight may cause poor fetal growth, 
but the reverse is also true. Poor fetal growth 
may be responsible for limited maternal weight 
gain. 
Suspected intrauterine growth retardation 
(IUGR) is another category that deserves special 
attention because of the difficulty of diagnosis. 
Suspected intrauterine growth retardation, as 
measured by biparietal diameter with ul­
trasound, is often an iatrogenic problem Er­
roneous measurements. or studies done too fre­
quently, may indicate that there is lack of 
growth in the biparietal diameter. This points to 
the possibility of placental or fetal compromise. 
although, in fact. it may be nothing more than 
laboratory error. 
Intrauterine growth retardation diagnosed 
prior to 28 weeks gestation should be extremely 
suspect. Even in placental insufficiency syn­
dromes. the fetal head usually continues to 
grow past 28 weeks, and it is extremely unlikely 
that the diagnosis of IUGR can be made from 
biparietal diameter data before that time. A 
biparietal diameter four or more weeks behind 
the dates prior to 28 weeks usually indicates 
"wrong dates." 
Hypertensive disorders in pregnancy are 
important because of their frequency and be­
cause of the profound effects they have both on 
the mother and the fetus. They are divided into 
the toxemias (eclampsia and preeclampsia). 
chronic hypertension, gestational hypertension, 
and toxemia superimposed on hypertension. 
Gestational hypertension is hypertension that is 
unmasked in pregnancy but without the criteria 
for the diagnosis of toxemia. 
Making the appropriate diagnosis of hy­
pertensive disorders in pregnancy can be con­
fusing. However, high blood pressure, regard­
less of etiology, has a deleterious effect on the 
end organs, be it the brain. the liver, the kidney, 
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the cardiovascular system or the placenta. 
While it is important to establish a diagnosis, it ist 
more important to realize that the magnitude o� 
the blood pressure and the extent of end organ 
damage is directly proportional to fetal-maternal 
morbidity and mortality. In a series of hyperten" 
sives with proteinuria, the perinatal mortality, 
rate was 3 7. 9 per 1 000 births. This compared 
with a rate of 17.2 per 1000 for normotensive 
patients without proteinuria. 2 In patients with· 
diastolic blood pressure greater than 120, the 
perinatal mortality is 50%. 3 
Hypertensive syndromes in pregnancy, 
continue to result in maternal mortality The out­
come is compromised particularly if accelerated: 
hypertension occurs in the third trimester. Gen­
erally this is categorized as chronic hyper­
tension with superimposed toxemia.' Chesley 
reports that hypertension is rarely aggravated in 
pregnancy unless there is significant cardiac, 
renal, or retinal pathology.• What must be em­
phasized. however, is that this type of pathol­
ogy is fairly common in hypertensives and when 
these women become pregnant they are at in­
creased risk. 
In the past several years much attention 
has been directed at predicting the patient who 
will develop hypertension in pregnancy. Dalton 
looked at weight gain as an indicator.6 She re­
ported the incidence of preeclampsia to be 
26% in patients who gained more than 1 % 
pounds per week after the 30th week of gesta­
tion. The weight gain she is alluding to is not 
really caloric weight gain but rather fluid reten­
tion which is one of the triad of symptoms asso­
ciated with preeclampsia Edema. however. 
does not correlate well with increased perinatal 
morbidity and mortality. In fact, fluid retention is 
the least significant of the triad of hypertension, 
proteinuria and edema in relationship to peri­
natal mortality. 3 Chesley has demonstrated that 
the diastolic blood pressure is the most signifi­
cant factor in patients who will develop hyper­
tension in pregnancy. 5 In his study, diastolic ele­
vation occurred as the first symptom in 58% of 
patients whereas proteinuria occurred as the 
first symptom in only 34%. Proteinuria is only a 
reflection of the end organ damage to the kid­
ney in hypertensives. In toxemia the vascular 
changes resulting in decreased perfusion of vi­
tal organs is frequently long standing prior to a 
noticeable elevation in the diastolic blood pres­
sure. Indeed, Gant and others' have demon-
strated that the vascular changes typical of tox­
emia occur as early as 24 weeks. Using 140/ 
90 as a standard, the physician may not be 
able to appreciate an elevation until 35 or 36 
weeks when end organ damage is already sub­
stantial. If the diastolic blood pressure is 75-85 
mm Hg, the perinatal mortality is about 7 per 
1000. As the diastolic pressure increases to 
85-90 mm Hg the rate is 10 per 1000. When 
the diastolic is 90-104 mm Hg, the perinatal 
mortality triples what it was at 7 5 mm Hg and 
there is a progressive linear increase in perinatal 
mortality as the diastolic blood pressure contin­
ues to elevate.' A diastolic reading of 90 mm 
Hg at any point in pregnancy is distinctly abnor­
mal. 
Calculation of the mean arterial pressure 
(MAP) is the most sensitive method of predicting 
impending hypertension in pregnancy. This 
measurement is obtained using the following 
formula. 
MAP = S
ystolic + 2 Diastolic 
3 
A MAP greater than 90 in the second trimester 
or greater than 105 in the third trimester is 
prognostic of hypertension, either gestational 
hypertension or toxemia.• 
Page and Christianson calculated MAP in 
the second and third trimesters and correlated it 
with outcome.• They found that when the MAP 
went from 90 to 95 or greater, the incidence of 
preeclampsia tripled. It is important to note that 
a blood pressure of 140/90 yields a MAP of 
well over 1 00. A blood pressure reading that 
may appear grossly normal is often abnormal 
when calculating its mean arterial pressure. 
Diabetes in pregnancy, while it represents 
a much smaller proportion of patients than the 
hypertensives, continues to be a problem. Dia­
betic pregnancies carry a perinatal death rate 
four to five times higher than normal preg­
nancies.• The outcome depends largely on the 
severity of the diabetes and the amount of vas­
cular disease present prior to pregnancy. Some 
of the common problems seen in these preg­
nancies are congenital anomalies (6%), oligohy­
dramnios, premature rupture of membranes, 
macrosomia, toxemia (13% to 50%), urinary 
tract infections, increased incidence of cesa­
rean section, birth trauma and intrauterine 
deaths. In addition, babies of diabetic mothers 
experience many problems in the newborn nur-
sery. They include hypoglycemia, respiratory 
distress syndrome, and hyperbilirubinemia. 
The key to improved outcome in diabetic 
pregnancies centers around early diagnosis and 
strict metabolic control. Patients with a family 
history of diabetes or macrosomic babies, 
(greater than 4000 grams) should have a glu­
cose tolerance test to screen for diabetes. In 
women who have had a previous baby weighing 
more than 4000 grams, 10% have undiag­
nosed diabetes. ' 0 These women have high 
blood sugars which stimulate the fetal pancreas 
to produce insulin. Insulin acts like growth hor­
mones in the fetus resulting in macrosomia. 
Glycosuria in pregnancy is another indicator to 
screen for diabetes. It cannot be dismissed as a 
decreased renal threshold for glucose or as ga­
lactosuria secondary to breast development. 
Any patient with glycosuria in pregnancy should 
be considered diabetic until proven otherwise. 
Finally, patients with a poor obstetrical his­
tory should be screened for diabetes. This in­
cludes previous congenital anomalies, stillbirth, 
and repeated pregnancy loss. 
In conclusion, the classification system 
developed at the Medical College of Virginia to 
identify the high-risk gravida has been pre­
sented with a discussion of some of the prob­
lems in pregnancy that carry a high perinatal 
mortality. The importance of classifying patients 
according to risk is emphasized so that appro­
priate management can ensue. In this way, 
pregnancy outcome can be improved. 
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